299 results on '"Yoshida, Yoichiro"'
Search Results
52. Severe gastrointestinal involvement predictive score in IgA vasculitis is also a risk factor for nephritis being varied depending on their ages of onset
53. The combination of TAS-102 and bevacizumab as the third-line chemotherapy for metastatic colorectal cancer (TAS-CC3 Study).
54. Transanal TME: new standard or fad?
55. Study Protocol of Regorafenib Escalation for Colorectal Cancer (RECC): A Phase II Multicenter Clinical Trial of the Efficacy and Safety of Regorafenib Dose Escalation Therapy as the Third or Fourth Line Therapy for Unresectable/Recurrent Colorectal Cancer
56. Pitfalls of Double Stapling Technique
57. Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study.
58. A case of carbon dioxide embolism during the transperineal approach in total pelvic exenteration for advanced anorectal cancer.
59. A Marked Response to Immunosuppressive Intervention for Abruptly Occurring Cardiac Complications in a Case of Juvenile Systemic Sclerosis Overlapped with Dermatomyositis
60. Biweekly Administration of TAS-102 for Neutropenia Prevention in Patients with Colorectal Cancer
61. MOESM2 of Comparison of intra-individual coefficients of variation on the paired sampling data when inter-individual variations are different between measures
62. Phase II study on early start of chemotherapy after excising primary colorectal cancer with distant metastases (Pearl Star 02)
63. Liposomal microparticle injection can induce myeloid-derived suppressor cells (MDSC)-like cells in vivo
64. Efficacy of Abdominal Fascia and Skin Closure Using Triclosan-Coated Sutures on Incidence of Superficial Incisional Surgical Site Infections after Gastroenterologic Surgery
65. Difference in Neutropenia due to Administration Schedule of TAS-102
66. Immunotherapy using activated T cells with chemotherapy for metastatic colorectal cancer.
67. Triclosan sutures for surgical site infection in colorectal cancer
68. Objective evaluation of oxaliplatin-induced vascular pain secondary to peripheral vein administration
69. Comparison of intra-individual coefficients of variation on the paired sampling data when inter-individual variations are different between measures
70. Phase II study of the early start of chemotherapy after excision of primary colorectal cancer with distant metastases (Pearl Star 02).
71. Clinical study on medical value of adoptive immunotherapy with chemotherapy for stage IV colorectal cancer (COMVI study).
72. Perioperative chemotherapy with S-1 plus oxaliplatin (SOX) for stage III colorectal cancer patients.
73. Potential of the 5-fluorouracil dose-escalation method for dihydropyrimidine dehydrogenase-deficient patients
74. A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial
75. Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy
76. Dexamethasone as a Means Not Only for Controlling Vascular Pain Caused by the Administration of Oxaliplatin Via the Peripheral Vein But Also for Controlling Oxaliplatin- Induced Hypersensitivity Reactions
77. Mitochondrial Transcription Factor A and Mitochondrial Genome as Molecular Targets for Cisplatin-Based Cancer Chemotherapy
78. Impact of perioperative probiotic treatment for surgical site infections in patients with colorectal cancer
79. Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy.
80. The difference between the subjective and objective evaluation of oxaliplatin-induced vascular pain due to administer chemotherapy via peripheral vein.
81. A validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: The AVOID trial.
82. Can grade 2 neutropenia predict the risk of grade 3 neutropenia in metastatic colorectal cancer patients treated with chemotherapy?
83. Administration of Chemotherapy Via Median Cubital Vein Without Central Venous Access Port for Colorectal Cancer
84. Evaluation of Phlebitis Attribute to Chemotherapy in Colorectal Cancer Patients of Our Institution
85. Tu1730 - Efficacy of Abdominal Fascia and Skin Closure Using Triclosan-Coated Sutures on Incidence of Superficial Incisional Surgical Site Infections after Gastroenterologic Surgery
86. A Report of Disseminated Carcinomatosis of the Bone Marrow Originating from Transverse Colon Cancer Successfully Treated with Chemotherapy Using XELOX plus Bevacizumab
87. Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients
88. Efficacy of XELOX plus Bevacizumab in Brain Metastasis from Rectal Cancer
89. Administration of chemotherapy via median cubital vein without implantable central venous access port for metastatic colorectal cancer: Port-free chemotherapy.
90. Endoscopic mucosal incision for successful treatment of submucosal abscess extending the full length of the esophagus due to fish bone: report of a case
91. A Study of the Efficacy of Antibacterial Sutures for Surgical Site Infection: A Retrospective Controlled Trial
92. Effect of coinfusion of dexamethasone to oxaliplatin on hypersensitivity reactions induced by oxaliplatin in patients with colorectal cancer treated with XELOX.
93. Can grade 2 neutropenia predict the risk of grade 3 neutropenia in metastatic colorectal cancer patients treated with chemotherapy?
94. A Successfully Resected Case of Recurrent Lung and Liver Metastases of Rectal Cancer Treated with XELIRI + Bevacizumab Therapy
95. Dexamethasone as a means for controlling vascular pain caused by the administration of oxaliplatin via the peripheral vein and also for controlling oxaliplatin-induced hypersensitivity reactions.
96. Dexamethasone as a Means Not Only for Controlling Vascular Pain Caused by the Administration of Oxaliplatin Via the Peripheral Vein But Also for Controlling Oxaliplatin-Induced Hypersensitivity Reactions
97. Oxaliplatin and pH
98. Multiple Ectopic Hepatocellular Carcinomas Arising in the Abdominal Cavity
99. Port Free Chemotherapy for Recurrent or Metastatic Colorectal Cancer. Is Port Really Necessary?
100. Early Start of Chemotherapy after Resection of Brain Metastasis from Colon Cancer with Synchronous Multiple Liver Metastases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.